Endolif

Germany-based medical device firm Joimax has expanded its invasive endoscopic spinal surgery portfolio with the launch of two new products, EndoLIF On-Cage and iLESSYS Delta interlaminar system.

EndoLIF is a 3D printed titanium alloy that is developed using special electron beam melting (EBM) technology.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The system has a porous surface with a diamond cell structure, providing an optimal base for cell proliferation and bone growth.

Filled with an autogenous bone, the system’s two large implant graft windows allow for bridging bone to further support fusion.

EndoLIF On-Cage implant enables surgeons to use a mini-open or an inter-muscular approach into the intervertebral disc space, allowing for endoscopic-assisted fusion.

The intermuscular approach is similar to a mini-transforaminal lumbar interbody fusion (TLIF) approach.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
“Joimax offers complete endoscopic solutions for spinal decompression, stabilisation and fusion.”

In July, the company secured 510(k) approval from US Food and Drug Administration (FDA) for the Endoscopic Lumbar Interbody Fusion or EndoLIF On-Cage implant. It also received approval from the FDA for Percusys percutaneous screw-rod system at the start of the year.

The company’s iLESSYS Delta system can be used for dorsal and dorso-lateral treatment of central spinal canal stenosis.

The instrument set comprises newly developed tools, which allow an extensive and tissue-sparing decompression.

A new endoscope with a 6mm working channel enables the use of large shaver blades developed for bone and tissue resection and other instruments can be used under full endoscopic view.

Joimax CEO Wolfgang Ries said: “Albert Telfeian and Jian Shen will be the first spinal surgeons in the US to perform surgeries with the new iLESSYS Delta endoscopic technology and the EndoLIF On-Cage implants.”

“With the new EndoLIF programme, combined with the TESSYS technology, and now the iLESSYS Delta, Joimax offers complete endoscopic solutions for spinal decompression, stabilisation and fusion.”

The company is exhibiting the EndoLIF system at the 30th Annual North American Spine Society (NASS) meeting in Chicago, which is being held from 14-17 October.

Image: Joimax EndoLIF On-Cage implant. Photo: courtesy of Business Wire.